2m 2m 2m 2m 2m 2m 2m
Merck (MRK)
NYSE
$153.33+$0.77 (+0.51%)
Price as of Aug 21, 2026 7:59 PM EDT- $367.6BMarket Cap
- 80.44%1-Year Change
- Drug Manufacturers - GeneralIndustry
Merck (MRK)
$153.33+$0.77 (+0.51%)
MRK | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $152.55 | ||
Change | +$3.56 (+2.39%) | ||
Open | $149.12 | ||
High | $154.49 | ||
Low | $148.59 | ||
Previous Close | $148.99 | ||
Volume | 15,976,222 | ||
30-Day Average Volume | 10,176,132 | ||
1-Week Change | 12.30% | ||
1-Month Change | 20.82% | ||
1-Year Change | 80.44% | ||
3-Year Change | 52.60% | ||
5-Year Change | 126.62% | ||
Fundamentals | |||
Shares Outstanding | 2.5B | ||
Total Assets | $129.8B | ||
Market Cap | $367.6B | ||
Enterprise Value | $414.6B | ||
Period: QTR TTM FY | |||
Revenue | $16.6B | ||
Net Income | -$1.3B | ||
Free Cash Flow | $4.5B | ||
EBIT | -$681.0M | ||
EBITDA | -$82.0M | ||
Net Working Capital | $8.9B | ||
EPS | -$0.54 | ||
Enterprise Value/EBITDA | -5,057 | ||
Enterprise Value/Revenue | 25 | ||
P/B | 9 | ||
P/E | -283 | ||
PEG | -4 | ||
Price/Free Cash Flow | 84 | ||
Price/Operating Cash Flow | 70 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 2.23% | ||
Trailing Annual Dividend Yield | 2.20% | ||
Ex-Dividend Date | 09/15/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue
Annual Dividend Yield